Goldman Sachs Maintains Buy on Ovintiv, Raises Price Target to $72
Benzinga Newsdesk 6 days ago
Analyst RatingsNewsPrice Target
Goldman Sachs analyst Neil Mehta maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $65 to $72.
Goldman Sachs analyst Neil Mehta maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $65 to $72.